Three FDA advisory panel members resign over approval of Alzheimer's drug. Mahase E. BMJ 2021;373:n1503.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Mahase E. Three FDA advisory panel members resign over approval of Alzheimer's drug. BMJ 2021;373:n1503.
PMID: 34117086